CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
DIAPATH SpA is developing Origin, a new tissue processing solution that minimizes chemical use and processing time, enhancing safety for operators. This innovation aims to streamline diagnostics in hospitals and laboratories while reducing environmental impact.
Current tissue processors on the market take up to 24 hours to process samples for diagnosis and leave the operator exposed to chemicals.
They also use different kinds of chemicals, in large volumes, which leads to cross contamination of chemicals and samples.
This results in more plastic packaging to dispose of, making the process both costly and environmental unfriendly.
Our company, DIAPATH SpA, is developing an innovative solution to these problems, Origin. DIAPATH has been in the tissue pro…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
